Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The new guideline for evaluating effects of psychotropic drugs on the performance to drive a motor vehicle in Japan: Comparison with US FDA guideline.
Iwamoto K, Nakabayashi T, Yamaguchi A, Konishi Y, Saji M, Yoshimura R, Kanemoto K, Aoki H, Ando M, Ozaki N. Iwamoto K, et al. Among authors: kanemoto k. Neuropsychopharmacol Rep. 2023 Jun;43(2):172-176. doi: 10.1002/npr2.12339. Epub 2023 Apr 14. Neuropsychopharmacol Rep. 2023. PMID: 37057649 Free PMC article. Review.
Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment.
Nakabayashi T, Iwamoto K, Yamaguchi A, Konishi Y, Saji M, Yoshimura R, Kanemoto K, Aoki H, Ando M, Ozaki N. Nakabayashi T, et al. Among authors: kanemoto k. Neuropsychopharmacol Rep. 2024 Jun;44(2):308-313. doi: 10.1002/npr2.12436. Epub 2024 Apr 16. Neuropsychopharmacol Rep. 2024. PMID: 38624143 Free PMC article. Review.
Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare guideline.
Iwamoto K, Nakabayashi T, Yamaguchi A, Konishi Y, Saji M, Yoshimura R, Kanemoto K, Aoki H, Ando M, Ozaki N. Iwamoto K, et al. Among authors: kanemoto k. Neuropsychopharmacol Rep. 2024 Dec;44(4):682-687. doi: 10.1002/npr2.12469. Epub 2024 Nov 4. Neuropsychopharmacol Rep. 2024. PMID: 39497515 Free PMC article. Review.
255 results